Wen Sen Li

Title: Innovations of Wen Sen Li in Epothilone Analog Preparation

Introduction

Wen Sen Li is a notable inventor based in Holmdel, NJ (US), recognized for his contributions to the field of pharmaceuticals. He holds two patents that focus on the preparation of epothilone analogs, which are significant in cancer treatment.

Latest Patents

His latest patents include a process for the preparation of epothilone analogs. This invention relates to a method that begins with the formation of novel ring-opened epothilones, followed by a macrolactamization reaction. The process is designed to be conducted in a single reaction vessel without the need for isolating the intermediate compound. This innovative approach provides at least a three-fold increase in yield compared to previous methods for preparing the desired epothilone analogs.

Career Highlights

Wen Sen Li is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work focuses on advancing drug development processes that can significantly impact patient care.

Collaborations

Throughout his career, Wen Sen Li has collaborated with esteemed colleagues, including John E. Thornton and Zhenrong Guo. These collaborations have contributed to the advancement of research and development in the pharmaceutical industry.

Conclusion

Wen Sen Li's innovative work in the preparation of epothilone analogs showcases his commitment to improving pharmaceutical processes. His contributions are vital in the ongoing fight against cancer, and his patents reflect significant advancements in the field.